Comment on "Non-Proportional Hazards – an Evaluation of the MaxCombo Test in Cancer Clinical Trials" by the Cross-Pharma Non-Proportional Hazards Working Group.
Saved in:
| Title: | Comment on "Non-Proportional Hazards – an Evaluation of the MaxCombo Test in Cancer Clinical Trials" by the Cross-Pharma Non-Proportional Hazards Working Group. |
|---|---|
| Authors: | Lin, Ray S.1 (AUTHOR), Mukhopadhyay, Pralay2 (AUTHOR), Roychoudhury, Satrajit3 (AUTHOR), Anderson, Keaven M.4 (AUTHOR), Hu, Tianle5 (AUTHOR), Huang, Bo6 (AUTHOR), Leon, Larry F.4 (AUTHOR), Liao, Jason J. Z.7 (AUTHOR), Lin, Ji8 (AUTHOR), Liu, Rong9 (AUTHOR), Luo, Xiaodong10 (AUTHOR), Mai, Yabing11 (AUTHOR), Qin, Rui12 (AUTHOR), Tatsuoka, Kay13 (AUTHOR), Wang, Yang14 (AUTHOR), Ye, Jiabu4 (AUTHOR), Zhu, Jian15 (AUTHOR), Chen, Tai-Tsang16 (AUTHOR), Iacona, Renee17 (AUTHOR) |
| Source: | Statistics in Biopharmaceutical Research. Apr-Jun2023, Vol. 15 Issue 2, p312-314. 3p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
